NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Genomic Analysis to Identify a Predictive Biomarker for Immunotherapy

RecruitingN/A

Sponsor: Samsung Medical Center

Conditions: Lung Cancer

Countries: South Korea

This study is designed to identify the predictive biomarker for immunotherapy using patient samples (tumor tissue, blood, fecal material) who treated with immune checkpoint inhibitor.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

1. aged above or equal to 18
2. Histologically confirmed lung cancer patients
3. Patient treated with immune checkpoint inhibitor

Exculsion Criteria:

NA

Locations (3)

Seoul, Gangnam-gu, South Korea
Seoul, Joungro-gu, South Korea
Seoul, Songpa-gu, South Korea